{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:16:37Z","timestamp":1780334197924,"version":"3.54.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004563","name":"Bayerisches Staatsministerium f\u00fcr Bildung und Kultus, Wissenschaft und Kunst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004563","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DFG","award":["WU 164\/5-1"],"award-info":[{"award-number":["WU 164\/5-1"]}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"publisher","award":["031A430E"],"award-info":[{"award-number":["031A430E"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.nbd.2017.05.013","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T18:32:43Z","timestamp":1496255563000},"page":"179-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse"],"prefix":"10.1016","volume":"105","author":[{"given":"F.","family":"Giesert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Glasl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Stautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"H\u00f6lter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Vogt Weisenhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Wurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.05.013_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/brain\/awq322","article-title":"The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation","volume":"134","author":"Alam","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.05.013_bb0010","doi-asserted-by":"crossref","first-page":"15846","DOI":"10.1523\/JNEUROSCI.4357-09.2009","article-title":"Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)","volume":"29","author":"Andres-Mateos","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0015","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1523\/JNEUROSCI.21-17-06588.2001","article-title":"Chronic blockade of glutamate receptors enhances presynaptic release and downregulates the interaction between synaptophysin-synaptobrevin-vesicle-associated membrane protein 2","volume":"21","author":"Bacci","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0020","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1460-9568.2006.05033.x","article-title":"Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease","volume":"24","author":"Baltadjieva","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fncel.2014.00301","article-title":"Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice","volume":"8","author":"Beccano-Kelly","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0030","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/hmg\/ddu543","article-title":"LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory","volume":"24","author":"Beccano-Kelly","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.013_bb0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCRESAHA.114.303819","article-title":"Reproducibility in science: improving the standard for basic and preclinical research","volume":"116","author":"Begley","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.nbd.2017.05.013_bb0040","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/124.11.2131","article-title":"Pathophysiology of bradykinesia in Parkinson's disease","volume":"124","author":"Berardelli","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.05.013_bb0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.26478","article-title":"DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease","volume":"31","author":"Bergareche","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070249","article-title":"Non-motor and motor features in LRRK2 transgenic mice","volume":"8","author":"Bichler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.013_bb0055","article-title":"LRRK2 and Parkinson's disease: from lack of structure to gain of function","author":"Blanca Ramirez","year":"2016","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0060","first-page":"209","article-title":"Postural instability and falls in Parkinson's disease","volume":"87","author":"Bloem","year":"2001","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbamcr.2003.08.008","article-title":"Roc, a Ras\/GTPase domain in complex proteins","volume":"1643","author":"Bosgraaf","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2017.05.013_bb0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2017.05.013_bb0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.nbd.2017.05.013_bb0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbr.2008.11.027","article-title":"Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl\/6J mice","volume":"198","author":"Byler","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2017.05.013_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2014.04.021","article-title":"(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse","volume":"68","author":"Chou","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.013_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","article-title":"Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment","volume":"182","author":"Cryan","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2017.05.013_bb0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1601-183X.2008.00412.x","article-title":"Genetic mouse models for behavioral analysis through transgenic RNAi technology","volume":"7","author":"Delic","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2017.05.013_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nchembio.538","article-title":"Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2","volume":"7","author":"Deng","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0105","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2013.05.034","article-title":"Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R(1)(4)(4)(1)G) transgenic mouse","volume":"549","author":"Dranka","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2017.05.013_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neulet.2014.09.042","article-title":"A novel mitochondrially-targeted apocynin derivative prevents hyposmia and loss of motor function in the leucine-rich repeat kinase 2 (LRRK2(R1441G)) transgenic mouse model of Parkinson's disease","volume":"583","author":"Dranka","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2017.05.013_bb0120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20100784","article-title":"Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)\/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization","volume":"430","author":"Dzamko","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2017.05.013_bb0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/1531-8257(199907)14:4<619::AID-MDS1011>3.0.CO;2-X","article-title":"Interference of rhythmic constraint on gait in healthy subjects and patients with early Parkinson's disease: evidence for impaired locomotor pattern generation in early Parkinson's disease","volume":"14","author":"Ebersbach","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","article-title":"Genetics of Parkinson disease: paradigm shifts and future prospects","volume":"7","author":"Farrer","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.nbd.2017.05.013_bb0135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrd4737","article-title":"Tackling reproducibility in academic preclinical drug discovery","volume":"14","author":"Frye","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2017.05.013_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0150","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mds.23499","article-title":"The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease","volume":"26","author":"Gaenslen","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0155","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","article-title":"G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies","volume":"78","author":"Gaig","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2017.05.013_bb0160","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.20808","article-title":"LRRK2 expression linked to dopamine-innervated areas","volume":"59","author":"Galter","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000109764","article-title":"Mutations in LRRK2 as a cause of Parkinson's disease","volume":"16","author":"Giasson","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.nbd.2017.05.013_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ana.20791","article-title":"Biochemical and pathological characterization of LRRK2","volume":"59","author":"Giasson","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063778","article-title":"Expression analysis of Lrrk1, LRRK2 and LRRK2 splice variants in mice","volume":"8","author":"Giesert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.013_bb0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2012.01.002","article-title":"Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb","volume":"235","author":"Glasl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0185","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/pr9008578","article-title":"Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2","volume":"9","author":"Gloeckner","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.nbd.2017.05.013_bb0190","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1586\/ern.09.115","article-title":"Olfactory dysfunction as a diagnostic marker for Parkinson's disease","volume":"9","author":"Haehner","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.nbd.2017.05.013_bb0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JPD-130278","article-title":"A clinical approach towards smell loss in Parkinson's disease","volume":"4","author":"Haehner","year":"2014","journal-title":"J. Parkinsons Dis."},{"issue":"2","key":"10.1016\/j.nbd.2017.05.013_bb0485","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/08977150150502613","article-title":"Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries","volume":"18","author":"Hamers","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2017.05.013_bb0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"issue":"May","key":"10.1016\/j.nbd.2017.05.013_bb0205","first-page":"7","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","author":"Hinkle","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2017.05.013_bb0210","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.05.013_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097988","article-title":"Lack of correlation between the kinase activity of LRRK2 harboring kinase-modifying mutations and its phosphorylation at Ser910, 935, and Ser955","volume":"9","author":"Ito","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.013_bb0220","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.05.013_bb0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/ddv453","article-title":"14-3-3 proteins regulate mutant LRRK2 kinase activity and neurite shortening","volume":"25","author":"Lavalley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.013_bb0230","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson's disease: from monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2017.05.013_bb0235","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0240","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0245","article-title":"Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.013_bb0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/acn3.45","article-title":"LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity","volume":"1","author":"Liu","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20121772","article-title":"Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle","volume":"456","author":"Lobbestael","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2017.05.013_bb0260","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","article-title":"The familial parkinsonism gene LRRK2 regulates neurite process morphology","volume":"52","author":"MacLeod","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.05.013_bb0265","doi-asserted-by":"crossref","first-page":"21386","DOI":"10.1074\/jbc.M113.528463","article-title":"Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution","volume":"289","author":"Mamais","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2017.05.013_bb0270","first-page":"121","article-title":"Neuromelanin and Parkinson's disease","volume":"19","author":"Marsden","year":"1983","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2017.05.013_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2017.05.013_bb0280","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neuroscience.2006.01.017","article-title":"Anatomical localization of leucine-rich repeat kinase 2 in mouse brain","volume":"139","author":"Melrose","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2017.05.013_bb0285","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.013_bb0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1901\/jeab.2000.73-305","article-title":"An olfactory discrimination procedure for mice","volume":"73","author":"Mihalick","year":"2000","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.nbd.2017.05.013_bb0295","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2017.05.013_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.22165","article-title":"Gait alterations in healthy carriers of the LRRK2 G2019S mutation","volume":"69","author":"Mirelman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0305","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1073\/pnas.1312701111","article-title":"Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3","volume":"111","author":"Muda","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.013_bb0310","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","article-title":"14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization","volume":"430","author":"Nichols","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2017.05.013_bb0315","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1042\/BST20160240","article-title":"L'RRK de Triomphe: a solution for LRRK2 GTPase activity?","volume":"44","author":"Nixon-Abell","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2017.05.013_bb0320","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","article-title":"The prediagnostic phase of Parkinson's disease","volume":"87","author":"Noyce","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2017.05.013_bb0325","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0330","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2017.05.013_bb0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JPD-130192","article-title":"LRRK2: cause, risk, and mechanism","volume":"3","author":"Paisan-Ruiz","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2017.05.013_bb0340","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nn.3636","article-title":"LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity","volume":"17","author":"Parisiadou","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1601-183X.2009.00559.x","article-title":"DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments","volume":"9","author":"Pham","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2017.05.013_bb0350","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1523\/JNEUROSCI.3730-10.2011","article-title":"LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool","volume":"31","author":"Piccoli","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132368","article-title":"Sleep disorders in parkinsonian and nonparkinsonian LRRK2 mutation carriers","volume":"10","author":"Pont-Sunyer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.05.013_bb0360","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/brain\/aws093","article-title":"How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder","volume":"135","author":"Postuma","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.05.013_bb0365","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0370","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000240220.33950.0c","article-title":"Parkinsonism, LRRK2 G2019S, and tau neuropathology","volume":"67","author":"Rajput","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2017.05.013_bb0375","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2014.00054","article-title":"LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status","volume":"7","author":"Reynolds","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0380","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/mds.23773","article-title":"Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations","volume":"26","author":"Ruiz-Martinez","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0385","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/acn3.95","article-title":"Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?","volume":"1","author":"Saunders-Pullman","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mds.870110103","article-title":"Internal tremor in patients with Parkinson's disease","volume":"11","author":"Shulman","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0395","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.24954","article-title":"Premotor Parkinson's disease: concepts and definitions","volume":"27","author":"Siderowf","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0400","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1460-9568.2006.04616.x","article-title":"LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain","volume":"23","author":"Simon-Sanchez","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2017.05.013_bb0405","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.05.013_bb0410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-014-3836-3","article-title":"Preclinical data reproducibility for R&D\u2014the challenge for neuroscience","volume":"232","author":"Steckler","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2017.05.013_bb0415","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0278-5846(87)90002-9","article-title":"The automated tail suspension test: a computerized device which differentiates psychotropic drugs","volume":"11","author":"Steru","year":"1987","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2017.05.013_bb0420","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2015.07.009","article-title":"An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease","volume":"82","author":"Tagliaferro","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.013_bb0425","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.conb.2004.10.003","article-title":"Functional diversity and specificity of neostriatal interneurons","volume":"14","author":"Tepper","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0430","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.013_bb0435","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice","volume":"107","author":"Tong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2017.05.013_bb0440","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00442824","article-title":"Genetic differences in a tail suspension test for evaluating antidepressant activity","volume":"99","author":"Trullas","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2017.05.013_bb0445","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2015.02.019","article-title":"Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease","volume":"77","author":"Tsika","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.05.013_bb0450","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.parkreldis.2012.03.024","article-title":"LRRK2 I2020T mutation is associated with tau pathology","volume":"18","author":"Ujiie","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0455","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.parkreldis.2015.07.025","article-title":"Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release","volume":"21","author":"Volta","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2017.05.013_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035035","article-title":"MAPK signaling determines anxiety in the juvenile mouse brain but depression-like behavior in adults","volume":"7","author":"Wefers","year":"2012","journal-title":"PLoS One"},{"issue":"Pt 1","key":"10.1016\/j.nbd.2017.05.013_bb0465","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.expneurol.2015.09.001","article-title":"(R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model","volume":"275","author":"Weng","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2017.05.013_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006013","article-title":"Animal models are valid to uncover disease mechanisms","volume":"12","author":"Wurst","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2017.05.013_bb0475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1474-9726.2009.00478.x","article-title":"Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels","volume":"8","author":"Yuan","year":"2009","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2017.05.013_bb0480","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117301237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:12:56Z","timestamp":1760850776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117301237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":97,"alternative-id":["S0969996117301237"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.05.013","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}